{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:02Z","timestamp":1791993842799,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.virol.2016.11.015","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T22:47:23Z","timestamp":1480978043000},"page":"147-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system"],"prefix":"10.1016","volume":"501","author":[{"given":"Jonathan C.","family":"Guito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar G.","family":"Albari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan K.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Towner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.virol.2016.11.015_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2016.11.015_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2014.12.002","article-title":"Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of host immune responses","volume":"476","author":"Albari\u00f1o","year":"2015","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.virol.2016.11.015_bib3","doi-asserted-by":"crossref","first-page":"e1002877","DOI":"10.1371\/journal.ppat.1002877","article-title":"Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection","volume":"8","author":"Amman","year":"2012","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.virol.2016.11.015_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3201\/eid2010.140696","article-title":"Marburgvirus resurgence in Kitaka Mine bat population after extermination attempts, Uganda","volume":"20","author":"Amman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7589\/2014-08-198","article-title":"Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus)","volume":"51","author":"Amman","year":"2015","journal-title":"J. Wildl. Dis."},{"issue":"10","key":"10.1016\/j.virol.2016.11.015_bib6","doi-asserted-by":"crossref","first-page":"e1002165","DOI":"10.1371\/journal.ppat.1002165","article-title":"Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm","volume":"7","author":"Balachandran","year":"2011","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.virol.2016.11.015_bib7","doi-asserted-by":"crossref","first-page":"e1002916","DOI":"10.1371\/journal.ppat.1002916","article-title":"Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism","volume":"8","author":"Bale","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.11.015_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virol.2015.03.030","article-title":"Innate immune evasion by filoviruses","volume":"479\u2013480","author":"Basler","year":"2015","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.virol.2016.11.015_bib9","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"Basler","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.virol.2016.11.015_bib10","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2016.11.015_bib11","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2016.11.015_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00705-013-1846-9","article-title":"Discussions and decisions of the 2012\u20132014 international committee on taxonomy of viruses (ICTV) Filoviridae study group, January 2012\u2013June 2013","volume":"159","author":"Bukreyev","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2016.11.015_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuw010","article-title":"Neglected filoviruses","author":"Burk","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/v2010262","article-title":"Evasion of the interferon-mediated antiviral response by filoviruses","volume":"2","author":"C\u00e1rdenas","year":"2010","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib16","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"C\u00e1rdenas","year":"2006","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib17","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JVI.03118-12","article-title":"Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences","volume":"87","author":"Carroll","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.015_bib18","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.5666.2","article-title":"Correlating the ability of VP24 protein from Ebola and Marburg viruses to bind human karyopherin to their immune suppression mechanism and pathogenicity using computational methods","author":"Chakraborty","year":"2014","journal-title":"F1000Research"},{"issue":"6","key":"10.1016\/j.virol.2016.11.015_bib19","doi-asserted-by":"crossref","first-page":"e1000493","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"Chang","year":"2009","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.virol.2016.11.015_bib20","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1021\/mp500646d","article-title":"A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infection","volume":"12","author":"Choi","year":"2015","journal-title":"Mol. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2016.11.015_bib21","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1093\/infdis\/jiv090","article-title":"High-resolution crystal Structure of dimeric VP40 from Sudan ebolavirus","volume":"212","author":"Clifton","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.virol.2016.11.015_bib22","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1080\/15384101.2015.1068472","article-title":"Predictive and comparative analysis of Ebolavirus proteins","volume":"14","author":"Cong","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.virol.2016.11.015_bib23","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1038\/ncomms9000","article-title":"Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses","volume":"6","author":"Dunham","year":"2015","journal-title":"Nat. Commun."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2016.11.015_bib24","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/infdis\/jiv050","article-title":"Marburg virus VP24 protein relieves suppression of the NF-kappaB pathway through interaction with Kelch-like ECH-associated protein 1","volume":"212","author":"Edwards","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2016.11.015_bib25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.celrep.2016.01.049","article-title":"Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins","volume":"14","author":"Edwards","year":"2016","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.virol.2016.11.015_bib26","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1128\/JVI.02069-14","article-title":"The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation","volume":"88","author":"Feagins","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.015_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virol.2015.07.010","article-title":"Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells","volume":"485","author":"Feagins","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2016.11.015_bib28","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","article-title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action","volume":"70","author":"Garc\u00eda","year":"2006","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib29","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/pr500556d","article-title":"Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function","volume":"13","author":"Garc\u00eda-Dorival","year":"2014","journal-title":"J. Proteome Res."},{"issue":"22","key":"10.1016\/j.virol.2016.11.015_bib30","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1073\/pnas.0603082103","article-title":"Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus","volume":"103","author":"Gitlin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 3","key":"10.1016\/j.virol.2016.11.015_bib31","doi-asserted-by":"crossref","first-page":"S953","DOI":"10.1093\/infdis\/jir325","article-title":"The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase","volume":"204","author":"Halfmann","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.virol.2016.11.015_bib32","first-page":"73","article-title":"The interferon response circuit in antiviral host defense","volume":"71","author":"Haller","year":"2009","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2005.09.024","article-title":"The interferon response circuit: induction and suppression by pathogenic viruses","volume":"344","author":"Haller","year":"2006","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/viro.1998.9446","article-title":"Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells","volume":"252","author":"Harcourt","year":"1998","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.virol.2016.11.015_bib35","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.00044-06","article-title":"Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication","volume":"80","author":"Hartman","year":"2006","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib36","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1128\/JVI.00215-08","article-title":"Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein","volume":"82","author":"Hartman","year":"2008","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2016.11.015_bib37","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/JVI.02344-07","article-title":"Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus","volume":"82","author":"Hartman","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2016.11.015_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI11918","article-title":"Hostile takeovers: viral appropriation of the NF-kappaB pathway","volume":"107","author":"Hiscott","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.virol.2016.11.015_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.it.2015.01.004","article-title":"Interferons and viruses: an evolutionary arms race of molecular interactions","volume":"36","author":"Hoffmann","year":"2015","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1189\/jlb.0107040","article-title":"Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2","volume":"84","author":"Hu","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"15","key":"10.1016\/j.virol.2016.11.015_bib41","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1128\/JVI.00924-15","article-title":"Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells","volume":"89","author":"Ilinykh","year":"2015","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2016.11.015_bib42","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/v7072779","article-title":"Experimental inoculation of Egyptian Rousette bats (Rousettus aegyptiacus) with viruses of the Ebolavirus and Marburgvirus genera","volume":"7","author":"Jones","year":"2015","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.virol.2016.11.015_bib43","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/JVI.80.6.3009-3020.2006","article-title":"Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence","volume":"80","author":"Kash","year":"2006","journal-title":"J. Virol."},{"issue":"7089","key":"10.1016\/j.virol.2016.11.015_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.0910547107","article-title":"Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression","volume":"107","author":"Kimberlin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.virol.2016.11.015_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chom.2011.03.007","article-title":"The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response","volume":"9","author":"Kok","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/107999002753452610","article-title":"Activities of IRF-1","volume":"22","author":"Kr\u00f6ger","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"issue":"4","key":"10.1016\/j.virol.2016.11.015_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/bsp.2011.0051","article-title":"Evaluation of perceived threat differences posed by filovirus variants","volume":"9","author":"Kuhn","year":"2011","journal-title":"Biosecur. Bioterror. Biodef. Strateg. Pract. Sci."},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib50","first-page":"1229","article-title":"Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA","volume":"159","author":"Kuhn","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2016.11.015_bib51","first-page":"484378","article-title":"TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?","author":"Kumar","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.virol.2016.11.015_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1073\/pnas.0807854106","article-title":"Structure of the Ebola VP35 interferon inhibitory domain","volume":"106","author":"Leung","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.virol.2016.11.015_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmb.2010.04.022","article-title":"Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain","volume":"399","author":"Leung","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.virol.2016.11.015_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nsmb.1765","article-title":"Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35","volume":"17","author":"Leung","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"17","key":"10.1016\/j.virol.2016.11.015_bib55","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1074\/jbc.M414139200","article-title":"Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.virol.2016.11.015_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/1079990041689665","article-title":"Induction and regulation of IFNs during viral infections","volume":"24","author":"Malmgaard","year":"2004","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.virol.2016.11.015_bib57","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JVI.01372-09","article-title":"Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling","volume":"84","author":"Mateo","year":"2010","journal-title":"J. Virol."},{"issue":"Suppl 3","key":"10.1016\/j.virol.2016.11.015_bib58","doi-asserted-by":"crossref","first-page":"S1011","DOI":"10.1093\/infdis\/jir338","article-title":"VP24 is a molecular determinant of Ebola virus virulence in guinea pigs","volume":"204","author":"Mateo","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"16","key":"10.1016\/j.virol.2016.11.015_bib60","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1074\/jbc.M807272200","article-title":"RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1","volume":"284","author":"Mikkelsen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.virol.2016.11.015_bib61","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","article-title":"Anti-TNF-alpha therapies: the next generation","volume":"2","author":"Palladino","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virol.2016.11.015_bib62","doi-asserted-by":"crossref","first-page":"23743","DOI":"10.1038\/srep23743","article-title":"Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses","volume":"6","author":"Pappalardo","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.virol.2016.11.015_bib63","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1128\/JVI.02536-07","article-title":"IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence","volume":"82","author":"Peters","year":"2008","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2016.11.015_bib64","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/v3091634","article-title":"Filoviral immune evasion mechanisms","volume":"3","author":"Ramanan","year":"2011","journal-title":"Viruses"},{"issue":"50","key":"10.1016\/j.virol.2016.11.015_bib65","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural basis for Marburg virus VP35-mediated immune evasion mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.virol.2016.11.015_bib66","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib67","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib68","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1189\/jlb.0607412","article-title":"poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages","volume":"83","author":"Reimer","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1998","journal-title":"FEBS Lett."},{"issue":"17","key":"10.1016\/j.virol.2016.11.015_bib70","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1128\/JVI.00523-09","article-title":"Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain","volume":"83","author":"Schumann","year":"2009","journal-title":"J. Virol."},{"issue":"Suppl 2","key":"10.1016\/j.virol.2016.11.015_bib71","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/520551","article-title":"Forty years of Marburg virus","volume":"196","author":"Slenczka","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.11.015_bib72","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2148-11-336","article-title":"Evolutionary maintenance of filovirus-like genes in bat genomes","volume":"11","author":"Taylor","year":"2011","journal-title":"BMC Evolut. Biol."},{"issue":"8","key":"10.1016\/j.virol.2016.11.015_bib73","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1371\/journal.pone.0000764","article-title":"Marburg virus infection detected in a common African bat","volume":"2","author":"Towner","year":"2007","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.virol.2016.11.015_bib74","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.virol.2016.11.015_bib75","doi-asserted-by":"crossref","first-page":"e1000536","DOI":"10.1371\/journal.ppat.1000536","article-title":"Isolation of genetically diverse Marburg viruses from Egyptian fruit bats","volume":"5","author":"Towner","year":"2009","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.virol.2016.11.015_bib76","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2016.11.015_bib77","doi-asserted-by":"crossref","first-page":"e1000721","DOI":"10.1371\/journal.ppat.1000721","article-title":"Marburg virus evades interferon responses by a mechanism distinct from ebola virus","volume":"6","author":"Valmas","year":"2010","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2016.11.015_bib78","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4049\/jimmunol.1000114","article-title":"NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication","volume":"185","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2016.11.015_bib79","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/1744666X.2014.908705","article-title":"Characterization of host immune responses in Ebola virus infections","volume":"10","author":"Wong","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.virol.2016.11.015_bib80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000289199","article-title":"Type I interferon: a new player in TNF signaling","volume":"11","author":"Yarilina","year":"2010","journal-title":"Curr. Dir. Autoimmun."},{"issue":"6","key":"10.1016\/j.virol.2016.11.015_bib81","doi-asserted-by":"crossref","first-page":"e20681","DOI":"10.1371\/journal.pone.0020681","article-title":"Negative regulation of interferon-beta gene expression during acute and persistent virus infections","volume":"6","author":"Ye","year":"2011","journal-title":"PloS One"},{"issue":"21","key":"10.1016\/j.virol.2016.11.015_bib82","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1128\/JVI.02163-14","article-title":"Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation","volume":"88","author":"Yen","year":"2014","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2016.11.015_bib83","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1128\/JVI.01727-15","article-title":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes","volume":"89","author":"Zaritsky","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2016.11.015_bib84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/viru.21302","article-title":"The ebolavirus VP24 interferon antagonist: know your enemy","volume":"3","author":"Zhang","year":"2012","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.virol.2016.11.015_bib85","doi-asserted-by":"crossref","first-page":"e1002550","DOI":"10.1371\/journal.ppat.1002550","article-title":"The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold","volume":"8","author":"Zhang","year":"2012","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2016.11.015_bib86","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.antiviral.2013.10.002","article-title":"Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit","volume":"100","author":"Zinzula","year":"2013","journal-title":"Antivir. Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216303695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216303695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:39:55Z","timestamp":1758587995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682216303695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":86,"alternative-id":["S0042682216303695"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727105187.793559614","asserted-by":"object"}]},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}